In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients
Hepatocellular carcinoma (HCC) is increasingly considered an issue of global importance. Its rates o...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
Hepatocellular carcinoma (HCC) is one of the deadliest cancer types worldwide. HCC is often diagnose...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Background. Hepatocellular carcinoma is a major health problem worldwide and the third most common c...
Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite the develo...
Background and aims: Circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) may be used for...
Abstract Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and high...
Hepatocellular carcinoma (HCC) is the most lethal and common type of liver cancer with limited treat...
Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is among the ma...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide, representing the third...
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass an annual i...
Hepatocellular carcinoma (HCC) is increasingly considered an issue of global importance. Its rates o...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
Hepatocellular carcinoma (HCC) is one of the deadliest cancer types worldwide. HCC is often diagnose...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Background. Hepatocellular carcinoma is a major health problem worldwide and the third most common c...
Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite the develo...
Background and aims: Circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) may be used for...
Abstract Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and high...
Hepatocellular carcinoma (HCC) is the most lethal and common type of liver cancer with limited treat...
Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is among the ma...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide, representing the third...
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass an annual i...
Hepatocellular carcinoma (HCC) is increasingly considered an issue of global importance. Its rates o...
International audienceHepatocellular carcinoma (HCC) is the most common liver tumor and among the de...
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in chronically inflame...
Add to ORKG